Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACYW135 meningococcal conjugate vaccine in children
CTR20161022Phase 3Completed
- Sponsor
- CanSino Biologics Inc.
- Start
- Jan 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Meningococcal conjugate vaccine quadrivalent in meningococcal meningitis, sponsored by CanSino Biologics Inc.. Started Jan 2017; status: completed.
02
Drugs
Meningococcal conjugate vaccine quadrivalent
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on CTR20161022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20161022.